Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol

BACKGROUND: Minimizing the risk of disease progression and exacerbations is the key goal of COPD management, as these are well-established indicators of poor COPD prognosis. We developed a novel composite end point assessing three important aspects (lung function, health status, and exacerbations) o...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Dave, Maleki-Yazdi, M Reza, Tombs, Lee, Iqbal, Ahmar, Fahy, William A, Naya, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928660/
https://www.ncbi.nlm.nih.gov/pubmed/27445468
http://dx.doi.org/10.2147/COPD.S101612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928660/
https://www.ncbi.nlm.nih.gov/pubmed/27445468
http://dx.doi.org/10.2147/COPD.S101612

Ejemplares similares